T-LIVEN PR™
GMP-ready human platelet lysate for closed system bioprocessing.
Building on the success of nLiven PR, T Liven PR combines closed system compatible packaging with release against a T-Cell growth release assay. Ensure your immune cells meet optimal cell quality. T-Liven PR consistently produces cells with improved naïve and central memory phenotype.
SPECIFICATIONS
DETAILS
- Validated pathogen reduction technology using E-Beam irradiation
- Released against a validated T-Cell growth promotion assay
- Available in bag format
- Large donor pool lot sizes
- Manufactured from outdated FDA/AABB approved apheresis platelet units
- FDA master file, PMDA Certificate of Suitability
- Used for manufacturing in US, EU, and other clinical trials globally
- Manufactured under a certified ISO 9001:2015 Quality Management System
- Example CoA and IFU
- Culture supplement to replace FBS or AB Serum
- Biodefined composition reduces lot-to-lot variability
- Supports a wide range of cell types including MSCs, T-Cells, NK Cells, Endothelial cells, and more
- Promotes improved in vitro and In vivo cell quality in CAR-T applications
- Typically used at concentrations ranging from 2% to 10%
- Used in 2D and 3D expansion systems
- Additional pathogen reduction applied per EU pharmacopeia